Evaluation of the Safety and Efficacy of Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Patients With Atrial Fibrillation (AF) and Hypertension (HTN)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The close relationship between the increase of sympathetic tension, AF, and HTN cannot be ignored. In addition, the significant failure rate of PVI (20-50%) in the treatment of AF makes it very necessary to explore the effect of RDN on AF. Therefore, this study aims to compare the effects and safety of PVI alone and PVI combined with RDN with AF combined with HTN, which will open a new chapter for PVI combined with RDN in the treatment of AF.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• 18\<age\<75years

• clinic blood pressure≥140/90mmHg or 24-hour ambulatory blood pressure monitoring average blood pressure ≥135/85mmHg

• Ecg diagnosis of atrial fibrillation ;

• who signed informed consent and were approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University.

Locations
Other Locations
China
the first affiliated hopital of Xiamen University
RECRUITING
Xiamen
Time Frame
Start Date: 2023-09-01
Estimated Completion Date: 2028-04-30
Participants
Target number of participants: 120
Treatments
Sham_comparator: PVI alone
Participants only experience PVI operations
Experimental: PVI and RDN
Participants experience both PVI and RDN operations
Related Therapeutic Areas
Sponsors
Leads: The First Affiliated Hospital of Xiamen University

This content was sourced from clinicaltrials.gov